TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 RISING DEMAND FOR PLASMA-DERIVED THERAPIES
4.2.3 FAVORABLE REIMBURSEMENT POLICIES
4.3 RESTRAINTS
4.3.1 HIGH PROCEDURE COSTS
4.3.2 SAFETY CONCERNS IN BLOOD TRANSFUSIONS
4.3.3 RECRUITMENT OF VOLUNTARY NON-REMUNERATED DONORS
4.4 OPPORTUNITY
4.4.1 INCREASING DEMAND FOR PLATELET-RICH PLASMA THERAPY
4.4.2 APHERESIS FOR LEUKEMIA AND PEDIATRIC PATIENTS
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE US APHERESIS MARKET
6 US APHERESIS SERVICE MARKET, BY SERVICE TYPE
6.1 OVERVIEW
7 US APHERESIS SERVICE MARKET, BY APPLICATION
7.1 OVERVIEW
8 US APHERESIS SERVICE MARKET, BY END USER
8.1 OVERVIEW
9 US APHERESIS SERVICE MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH
9.3 SOUTH
9.4 MIDWEST
9.5 WEST
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2024
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.1.1 FACILITY LAUNCH
10.1.2 ACQUISITION
10.1.3 PARTNERSHIP
10.1.4 TRANSITION
11 COMPANY PROFILES
11.1 VERSITI
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 FRESENIUS MEDICAL CARE AG
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 VITALANT
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 CARTER BLOODCARE
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIES
11.5 IMPACTLIFE
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (MFMER)
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 NEW YORK BLOOD CENTER (NYBC)
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 THE AMERICAN NATIONAL RED CROSS
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 BIOBRIDGE GLOBAL
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 SAN DIEGO BLOOD BANK
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 US APHERESIS SERVICE MARKET, BY SERVICE TYPE, 2019–2035 (USD MILLION)
TABLE 3 US APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 4 US APHERESIS SERVICE MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 5 US APHERESIS SERVICE MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 6 US APHERESIS SERVICE MARKET, BY REGION, 2019-2035 (USD MILLION)
TABLE 7 NORTH: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019–2035 (USD MILLION)
TABLE 8 NORTH: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019–2035 (USD MILLION)
TABLE 9 NORTH: APHERESIS SERVICE MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 10 NORTH: APHERESIS SERVICE MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 11 SOUTH: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019–2035 (USD MILLION)
TABLE 12 SOUTH: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019–2035 (USD MILLION)
TABLE 13 SOUTH: APHERESIS SERVICE MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 14 SOUTH: APHERESIS SERVICE MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 15 MIDWEST: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019–2035 (USD MILLION)
TABLE 16 MIDWEST: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019–2035 (USD MILLION)
TABLE 17 MIDWEST: APHERESIS SERVICE MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 18 MIDWEST: APHERESIS SERVICE MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 19 WEST: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019–2035 (USD MILLION)
TABLE 20 WEST: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019–2035 (USD MILLION)
TABLE 21 WEST: APHERESIS SERVICE MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 22 WEST: APHERESIS SERVICE MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 23 FACILITY LAUNCH
TABLE 24 ACQUISITION
TABLE 25 PARTNERSHIP
TABLE 26 TRANSITION
TABLE 27 VERSITI: SERVICES OFFERED
TABLE 28 VERSITI: KEY DEVELOPMENTS
TABLE 29 FRESENIUS MEDICAL CARE AG: SERVICES OFFERED
TABLE 30 VITALANT: SERVICES OFFERED
TABLE 31 VITALANT: KEY DEVELOPMENTS
TABLE 32 CARTER BLOODCARE: SERVICES OFFERED
TABLE 33 CARTER BLOODCARE: KEY DEVELOPMENTS
TABLE 34 IMPACTLIFE: SERVICES OFFERED
TABLE 35 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (MFMER): SERVICES OFFERED
TABLE 36 NEW YORK BLOOD CENTER (NYBC): SERVICES OFFERED
TABLE 37 THE AMERICAN NATIONAL RED CROSS: SERVICES OFFERED
TABLE 38 BIOBRIDGE GLOBAL: SERVICES OFFERED
TABLE 39 SAN DIEGO BLOOD BANK: SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 US APHERESIS SERVICE MARKET: STRUCTURE
FIGURE 2 US APHERESIS MARKET: MARKET GROWTH FACTOR ANALYSIS (2025-2035)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2035)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2035)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: US APHERESIS MARKET
FIGURE 6 US APHERESIS SERVICE MARKET SERVICE TYPE SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 7 US APHERESIS SERVICE MARKET, BY SERVICE TYPE, 2024 & 2035 (USD MILLION)
FIGURE 8 US APHERESIS SERVICE MARKET SHARE (%), BY SERVICE TYPE, 2024
FIGURE 9 US APHERESIS SERVICE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 10 US APHERESIS SERVICE MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION)
FIGURE 11 US APHERESIS SERVICE MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 12 US APHERESIS SERVICE MARKET, END USER SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 13 US APHERESIS SERVICE MARKET, BY END USER, 2024 & 2035 (USD MILLION)
FIGURE 14 US APHERESIS SERVICE MARKET SHARE (%), BY END USER, 2024
FIGURE 15 US MARKET ANALYSIS: APHERESIS SERVICE MARKET, 2019-2035 (USD MILLION)
FIGURE 16 US APHERESIS SERVICE MARKET, BY REGION, 2024 & 2035 (USD MILLION)
FIGURE 17 US APHERESIS SERVICE MARKET SHARE (%), BY REGION, 2024
FIGURE 18 US APHERESIS SERVICES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 19 COMPETITOR DASHBOARD: US APHERESIS SERVICES MARKET
FIGURE 20 VERSITI: SWOT ANALYSIS
FIGURE 21 FRESENIUS MEDICAL CARE AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 FRESENIUS MEDICAL CARE AG: SWOT ANALYSIS
FIGURE 23 VITALANT: SWOT ANALYSIS
FIGURE 24 NEW YORK BLOOD CENTER (NYBC): SWOT ANALYSIS
FIGURE 25 THE AMERICAN NATIONAL RED CROSS: SWOT ANALYSIS
